UPDATE 2-Juno cancer study halted after patient deaths, shares slide 30 pct

July 7 (Reuters) - A trial of Juno Therapeutics Inc's

genetically engineered cancer therapy, known as

JCAR015, was put on hold by U.S. regulators after three leukemia

patients died from side...

Read more